Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
1–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Current diagnosis of Chronic Kidney Disease, either receiving or not receiving dialysis
Anemic, with two consecutive screening hemoglobin values drawn at least 7 days apart \< 11.0 g/dL
Transferrin saturation (Tsat) greater than or equal to 20%
You may not be if
Any erythropoiesis stimulating agent (ESA) use within 12 weeks prior to randomization
other hematologic disorders
upper or lower gastrointenstinal bleeding within 6 months prior to randomization
uncontrolled hypertension
prior history (within 12 weeks prior to randomization) of acute myocardial ischemia, hospitalization for congestive heart failure, myocardial infarction, stroke or transient ischemic attack
prior history (within 6 months prior to randomization) of thromboembolism
Clareo Health | Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
